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1  | INTRODUCTION
Australia has one of the highest incidence rates of colorectal can‐
cer (CRC) in the world, with cases expected to continue increasing 
(Australian Institute of Health & Welfare, 2017b; Ferlay et al., 2013). 
It is estimated that one in 13 Australians will receive a CRC diagnosis 
during their lifetime. CRC is the second most common cancer type 
among both men and women in Australia, following prostate and 
breast cancer (Australian Institute of Health & Welfare, 2017b), and 
responsible for the second highest cancer‐related burden of disease 
(Australian Institute of Health & Welfare, 2017a). As the primary 
cause of death for approximately 4,120 Australians in 2014 (9% of 
total cancer deaths), CRC represents a substantial and increasing 
burden to the population's health and the nation's health resources.
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Introduction: Australia has one of the highest incidence rates of colorectal cancer 
(CRC) in the world. Residents in rural areas of Australia experience disadvantage 
in health care and outcomes. This review investigates whether patients with CRC 
in rural areas demonstrate poorer survival and more advanced stages of disease at 
diagnosis.
Methods: Systematic review of peer‐reviewed articles and grey literature. Studies 
were included if they provided data on survival or stage of disease at diagnosis across 
multiple geographical locations; focused on CRC patients; and were conducted in 
Australia.
Results: Twenty‐six articles met inclusion criteria. Twenty‐three studies examined 
survival, while five studies investigated stage at diagnosis. The evidence suggests 
that non‐metropolitan patients are less likely to survive CRC for five years compared 
to patients living in metropolitan areas, yet there was limited evidence to suggest 
geographical disparity in stage of diagnosis.
Conclusions: While five‐year survival disparities are apparent, these patterns appear 
to vary as a function of specific region and health jurisdiction, cancer type and year/s 
of data collection. Future research should examine current data using consistent and 
robust methods of reporting survival and classifying geographical location. The im‐
pact of population‐level screening programmes on survival and stage at diagnosis 
also needs to be thoroughly explored.
K E Y WO RD S
colorectal cancer, cancer screening, cancer survival, population health, systematic review, 
rural health, health disparities
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It is estimated that on average, Australians diagnosed with CRC 
have a 68% chance of surviving for five years or more (Australian 
Institute of Health & Welfare, 2017b). Unfortunately, residents of 
regional, rural and remote areas of Australia experience greater dis‐
advantage in health care and outcomes (Duckett, 2016). In terms of 
cancer care, this is observed in lower involvement in preventative 
approaches, reduced access to timely and up‐to‐date treatments, 
limited psychosocial support and reduced access to specialist care 
(Australian Institute of Health & Welfare, 2016; Dunn et al., 2013; 
Lejeune et al., 2010; Veitch, Crossland, Steeghs, Ho, & Hanks, 2008). 
These disadvantages may contribute to reduced CRC survival rates 
for Australians living outside metropolitan centres. An important 
contributor to reduced survival rates in non‐metropolitan areas is 
that individuals residing in these areas may be diagnosed at a later 
stage of disease (Baade, Dasgupta, Aitken, & Turrell, 2011b). For ex‐
ample, evidence has indicated that patients in rural areas are more 
likely to be diagnosed with advanced cancers, including breast and 
lung (Heathcote & Armstrong, 2007; Jong et al., 2004; Nguyen‐
Pham, Leung, & McLaughlin, 2014).
A recent systematic review reported evidence of geographic 
variations in CRC management and outcomes (Ireland et al., 2017). 
However, the evidence relating to survival was not conclusive, 
and evidence regarding stage at diagnosis was insufficient. These 
findings underscored the need for a more in‐depth examination of 
geographical disparities in survival and stage at diagnosis utilising 
clinical and government reports as well as peer‐reviewed literature. 
Thus, the current review involves a comprehensive and focused lit‐
erature search, containing potentially informative “grey” literature 
(e.g. government reports). The aim was to systematically retrieve and 
synthesise all available evidence relating to geographic variations in 
CRC stage at diagnosis and survival rates in Australia.
2  | METHODS
The review protocol was registered with PROSPERO (https ://www.
crd.york.ac.uk/PROSP ERO/displ ay_record.asp?ID=CRD42 01604 
2666) and was conducted and reported following the PRISMA state‐
ment (Liberati et al., 2009). Two clinical questions guided the review:
1. For individuals diagnosed with CRC, do those who reside in 
non‐metropolitan areas have poorer survival rates than those 
living in metropolitan areas of Australia?
2. For individuals diagnosed with CRC, do those living in non‐metro‐
politan areas have a more advanced stage of cancer at diagnosis 
compared with those living in metropolitan areas of Australia?
2.1 | Search strategy
The literature search followed a two‐stage process. First, peer‐re‐
viewed publications were searched utilising CINAHL, Medline, 
PsycInfo, Embase and Informit databases. The search covered all 
articles in these databases from January 1990 to January 2019. 
Search terms were based on keywords, subject headings and MeSH 
terms relating to “colorectal cancer” or “bowel cancer,” and “survival” 
or “mortality” or “cancer staging” or “spread.” Terms relating to geo‐
graphic variation included “geography” or “metropolitan” or “urban” 
or “rural” or “remote” or “regional.” Full syntax for the electronic 
search is available in Appendix A.
An additional search of grey literature was conducted through 
searching key government websites, Australian cancer organisations 
such as state Cancer Councils, Internet search engines (Google) and 
bibliographies of included studies.
2.2 | Eligibility criteria
Studies were included if data reported were from Australia; the 
sample included patients with CRC or there was a CRC‐specific 
subgroup; data were presented on metropolitan versus non‐metro‐
politan comparisons; data reported on outcome measures pertaining 
to survival or mortality (relative risk, hazard ratio or standardised 
mortality etc.) and/or stage at diagnosis. Studies were excluded if 
the study was qualitative, or if the study was not available in English. 
Review articles, theses, conference proceedings, editorials and com‐
mentaries were also excluded.
2.3 | Study selection and data extraction
After removing duplicates, titles and abstracts were independently 
screened by two reviewers to determine relevance according to the 
selection criteria. Full‐text versions of each article deemed to be rel‐
evant were then retrieved and screened. Reviewer discrepancies at 
either stage were discussed and resolved within the project team. 
Data extracted from each included study were study population, di‐
agnosis period, rural/urban definition, measure of survival or stage 
at diagnosis and key findings. It was determined that a meta‐analysis 
could not be undertaken due to the inconsistent definitions of rural‐
ity and lack of standardisation in data presentation.
2.4 | Risk of bias assessment
Quality assessments were conducted using a tool developed for 
research in breast cancer, based on the Newcastle‐Ottawa Scale 
(Wells et al., 2000; Youl et al., 2016). Individual studies were rated 
on a scale of 0 (high risk of bias), 1 (intermediate risk of bias) and 2 
(low risk of bias) according to nine criteria and then categorised into 
“high” (14–18), “moderate” (9–13) or “low” (<9) overall quality.
3  | RESULTS
Database searching identified 457 records in total. After removal 
of duplicates, 390 records were screened by title and abstract. Of 
those, 95 full‐text articles were deemed relevant to the current re‐
search questions and were assessed for eligibility. Following full‐text 
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assessment, 16 peer‐reviewed articles were included in the final re‐
view. Grey literature searching identified 10 additional reports to be 
included in the review, thus the total number of included studies was 
26 (see Figure 1).
3.1 | Study characteristics
Of the 26 studies included, 23 reported on a comparison in survival 
rates between CRC patients in metropolitan versus non‐metropolitan 
areas, and 5 studies provided information on disparities in stage at 
diagnosis, with two studies investigating both. Tables 1 and 2 provide 
details of the included studies, such as author, design, population, 
outcome, key findings and quality rating. Where studies included 
findings from several time periods (e.g. 1980–1986 and 2005–2010), 
we chose to report findings from the most recent period. This allowed 
us to make interpretations based on the most current findings.
3.2 | Study quality
Overall, the evidence reviewed was generally of high quality. The 
majority of studies (N = 17, 65%) received a high‐quality rating, 
while the rest were of moderate quality (N = 9, 35%), and no stud‐
ies were classified as low quality. The substantive meaning of the 
results did not appear to vary according to study quality. For the 
studies that examined survival disparities, 15 were high quality and 
of these, seven showed significant geographical disparities. Eight 
studies were deemed moderate quality with four of these reporting 
significant disparities. For studies examining differences in stage at 
diagnosis, four studies were considered to be high quality and one 
(from the grey literature) was moderate. Again this did not appear to 
have any bearing on the significance of findings.
3.3 | Geographical classification
Studies included in this review used various methods to classify 
geographical location. A number of studies adopted a simple classi‐
fication of metropolitan versus non‐metropolitan, whereas others 
utilised standardised classification systems such as the Australian 
Standard Geographic Classification (ASGC) Remoteness Areas 
and the Accessibility/Remoteness Index of Australia (ARIA). The 
ASGC and ARIA classification systems both allocate local gov‐
ernment areas to one of five categories. These categories are as 
follows: major city (or highly accessible); inner regional (or acces‐
sible); outer regional (or moderately accessible); remote; and very 
remote. However, due to smaller numbers in regional locations, 
many studies combine areas into three (metropolitan, regional, 
remote) or four categories (metropolitan, inner regional, outer re‐
gional and remote/very remote).
F I G U R E  1   Flow diagram of included studies
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TA B L E  1   Characteristics of included studies (geographic variations in CRC survival)
Study Design and data source
Diagnosis 
Period Population Rural/urban definition Outcome(s) Key findings
Statistical inference of 






wide registry study (QLD)
1996–2006 All patients aged 20–79 
diagnosed with inva‐
sive rectal cancer in 
QLD (N = 6,848)
Distance and travel 
time to radiotherapy 
facilities calculated 
using GIS applications
Cause‐specific 5 year relative 
survival rates (%)
Survival rates across different road dis‐
tances:	<50	km	=	64.5%;	50−99	km	=	60.9%;	
100−199	km	=	59.6%;	200−399	km	=	58.0%;	
>400 km = 57.4%. 
Adjusted hazard ratio (95% CI): <50 km = 1.00; 
50−99	km	=	1.03	(0.87–1.22);	100−199	km	=	1.16	
(1.00–1.34);	200−399	km	=	1.30	(1.15–1.47);	
>400 km = 1.25 (1.07–1.47). 
Survival rates across different travel times: 
0–1 hr = 64.3%; 1–2 hr = 59.4%; 2–4 hr = 58.3%; 
4–6 hr = 58.6%; >6 hr = 55.1%. 
Adjusted hazard ratio (95% CI): 0–1 hr = 1.00; 
1–2 hr = 1.07 (0.93–1.23); 2–4 hr = 1.28 (1.13–1.45); 
4–6 hr = 1.24 (1.08–1.44); >6 hr = 1.22 (0.85–1.76).
Chi‐square tests for distance 
model: p < 0.001 
Chi‐square test for travel time 
model: p < 0.001
High (16) After adjusting for age, sex and stage at 
diagnosis, patients who lived 100–199 km, 
200–399 km and 400 km or more from a ra‐
diotherapy facility were 16%, 30% and 25%, 
respectively, more likely to die from rectal 
cancer than patients living within 50 km of 
such a facility. 
Similarly, patients who travelled 2–4 hr, 
4–6 hr and >6 hr for treatment were 28%, 
24% and 22%, respectively, more likely to 
die from rectal cancer than patients travel‐





wide registry study (QLD)
1996–2007 Patients aged 
20–84 years diag‐
nosed with invasive 
stage I‐IV CRC 
(N = 22,727)
ARIA + (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Survival rates by region: major city = 68.1%, inner 
regional = 65.9%, outer regional = 61.6%, remote 
(includes very remote) = 59.6%. 
Adjusted odds ratio (95% CI): major city = 1.00; inner 
regional = 0.98 (0.90, 1.06); outer regional = 1.15 
(1.05, 1.25); remote = 1.24 (1.07, 1.42).
Log‐rank test for ARIA: 
p = 0.003
High (17) After adjusting for age, sex and stage at 
diagnosis, patients living in outer regional 
and remote areas were significantly more 
likely to die from colorectal cancer; however, 
patients in inner regional areas were less 
likely to die than metropolitan patients.
Beckmann et al. 
(2016)*
Retrospective population‐
wide registry study (SA)
2003–2008 All cases of CRC 
aged 50–79 years 
(N = 4,641)
ARIA (5 categories) Cause‐specific 5 year relative 
survival rates (%)
Survival rates across ARIA regions: inner urban = 69%, 
outer urban = 71%, rural = 68%, remote = 64%, very 
remote = 59%. 
Hazard ratio (95% CI): urban = 1.00; outer 
urban = 0.95 (0.79–1.16); rural = 0.98 (0.82–1.17); 
remote = 1.12 (0.90–1.39).
Kaplan–Meier log‐rank test for 
ARIA: p = 0.219
High (16) Survival rates across regions were not sig‐
nificantly different for all stages; however, 
patients residing in remote locations had 
significantly worse outcomes than met‐
ropolitan residents, though this was only 
evident for stages A‐C (HR = 1.35, 95% CI 
1.01–1.80).
Chen et al. (2015) Retrospective popula‐
tion‐wide registry study 
(NSW)
2000–2008 Patients diagnosed 
with any of 5 cancers 
(N = 39,333 CRC 
patients)
ARIA+ (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Significant differences in survival identified in adjusted 
regression models: Metastatic colon cancer in Outer 
Regional areas (HR = 1.14, 1.01–1.29); and localised 
rectal cancer in Outer Regional areas (HR = 1.68, 
1.02–2.77) and for regionalised rectal cancer in Inner 
Regional (HR = 1.14, 1.002–1.30).
Log‐rank test: p < 0.05 High (15) After adjusting for gender and age, where 
significant differences were found, major 
cities tended to show the best survival, 
whereas outer regional areas tended to 
show the worst for both metastatic colon 
and localised rectal cancer.
Coory et al. 
(2013)
Retrospective population‐
wide mortality analysis 
using ABS data





Excess cause‐specific deaths and 
age‐standardised mortality ratios 
(SMRs)
For men with CRC: number of excess cancer deaths in 
regional and remote areas = 407 (95% CI, 242–576). 
SMR = 1.05 (1.02–1.09). 
For women with CRC: number of excess cancer 
deaths in regional and remote areas = 343 (95% CI, 
197–492) compared with metro areas. SMR = 1.06 
(1.02–1.10)
Significant at the 0.05 level Moderate 
(13)
There was an increased number of excess 
deaths in regional and remote areas com‐
pared to metropolitan areas. For both men 
and women, mortality rates in regional and 
remote areas were higher than rates in the 
metro population.
Cramb et al. 
(2012)
Retrospective population‐
wide registry study (QLD)
1996–2007 Patients < 90 years in 
Queensland diagnosed 
with CRC (N = 26,390)
Distance to treatment: 
<2 hr, 2–6 hr, and 6+ hr
Relative excess risk of cancer 
death (RER) within 5 years of 
diagnosis
Survival estimates: <2 hr = 64.9%; 2–6 hr = 60.6%; 
>6 hr = 59.7%. 
Adjusted RER estimates: <2 hr = 1.00; 2–6 hr = 0.99 
(0.91–1.06); >6 hr = 1.07 (0.97–1.16). 
Of the 6,019 CRC deaths within 5 years of diagnosis 
in QLD, 470 (8%) would not have occurred if there 
were no spatial inequalities in the non‐diagnostic 
survival component (after adjusting for stage, age and 
gender)
Log‐rank test: p < 0.001 High (17) Risk of death was slightly lower for patients 
travelling	2−6	hr	to	treatment	and	higher	for	
patients travelling 6+ hr to treatment com‐
pared to those travelling less than 2 hr to 
treatment (adjusting for age, gender, stage, 
distance and area disadvantage).
Hall et al. (2005) Retrospective population‐
wide data linkage study 
(WA)
1991–2001 WA residents with di‐
agnosis of invasive pri‐
mary CRC (N = 10,217)
ARIA (5 categories) Five‐year all‐cause mortality Cox regression analysis or the likelihood of death 
from any cause according to ARIA (HR, 95% CI): Very 
accessible = HR 1.00; accessible = 0.85 (0.71–1.02); 
mod accessible = 1.10 (0.90–1.34); remote = 1.19 
(0.85–1.66); very remote = 1.05 (0.71–1.54)
Not reported High (17) Residency in rural areas or admission to a 
rural hospital had no effect on the likelihood 
of death.
Hocking et al. 
(2014)
Retrospective population‐
wide data linkage study 
(SA Clinical Registry for 
Metastatic CRC)
2006–2012 SA patients with meta‐
static CRC (N = 2,289)
Postcodes within state 
capital Adelaide were 
“city” cohort; remain‐
ing postcodes were 
“rural” cohort
Median overall survival (months) Median survival: 
city = 14.6 months 
rural = 14.9 months
Log‐rank test: p = 0.18 Moderate 
(13)
No significant differences in median survival 
were noted between metropolitan and rural 
patients.
(Continues)
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Statistical inference of 






wide registry study (QLD)
1996–2006 All patients aged 20–79 
diagnosed with inva‐
sive rectal cancer in 
QLD (N = 6,848)
Distance and travel 
time to radiotherapy 
facilities calculated 
using GIS applications
Cause‐specific 5 year relative 
survival rates (%)
Survival rates across different road dis‐
tances:	<50	km	=	64.5%;	50−99	km	=	60.9%;	
100−199	km	=	59.6%;	200−399	km	=	58.0%;	
>400 km = 57.4%. 
Adjusted hazard ratio (95% CI): <50 km = 1.00; 
50−99	km	=	1.03	(0.87–1.22);	100−199	km	=	1.16	
(1.00–1.34);	200−399	km	=	1.30	(1.15–1.47);	
>400 km = 1.25 (1.07–1.47). 
Survival rates across different travel times: 
0–1 hr = 64.3%; 1–2 hr = 59.4%; 2–4 hr = 58.3%; 
4–6 hr = 58.6%; >6 hr = 55.1%. 
Adjusted hazard ratio (95% CI): 0–1 hr = 1.00; 
1–2 hr = 1.07 (0.93–1.23); 2–4 hr = 1.28 (1.13–1.45); 
4–6 hr = 1.24 (1.08–1.44); >6 hr = 1.22 (0.85–1.76).
Chi‐square tests for distance 
model: p < 0.001 
Chi‐square test for travel time 
model: p < 0.001
High (16) After adjusting for age, sex and stage at 
diagnosis, patients who lived 100–199 km, 
200–399 km and 400 km or more from a ra‐
diotherapy facility were 16%, 30% and 25%, 
respectively, more likely to die from rectal 
cancer than patients living within 50 km of 
such a facility. 
Similarly, patients who travelled 2–4 hr, 
4–6 hr and >6 hr for treatment were 28%, 
24% and 22%, respectively, more likely to 
die from rectal cancer than patients travel‐





wide registry study (QLD)
1996–2007 Patients aged 
20–84 years diag‐
nosed with invasive 
stage I‐IV CRC 
(N = 22,727)
ARIA + (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Survival rates by region: major city = 68.1%, inner 
regional = 65.9%, outer regional = 61.6%, remote 
(includes very remote) = 59.6%. 
Adjusted odds ratio (95% CI): major city = 1.00; inner 
regional = 0.98 (0.90, 1.06); outer regional = 1.15 
(1.05, 1.25); remote = 1.24 (1.07, 1.42).
Log‐rank test for ARIA: 
p = 0.003
High (17) After adjusting for age, sex and stage at 
diagnosis, patients living in outer regional 
and remote areas were significantly more 
likely to die from colorectal cancer; however, 
patients in inner regional areas were less 
likely to die than metropolitan patients.
Beckmann et al. 
(2016)*
Retrospective population‐
wide registry study (SA)
2003–2008 All cases of CRC 
aged 50–79 years 
(N = 4,641)
ARIA (5 categories) Cause‐specific 5 year relative 
survival rates (%)
Survival rates across ARIA regions: inner urban = 69%, 
outer urban = 71%, rural = 68%, remote = 64%, very 
remote = 59%. 
Hazard ratio (95% CI): urban = 1.00; outer 
urban = 0.95 (0.79–1.16); rural = 0.98 (0.82–1.17); 
remote = 1.12 (0.90–1.39).
Kaplan–Meier log‐rank test for 
ARIA: p = 0.219
High (16) Survival rates across regions were not sig‐
nificantly different for all stages; however, 
patients residing in remote locations had 
significantly worse outcomes than met‐
ropolitan residents, though this was only 
evident for stages A‐C (HR = 1.35, 95% CI 
1.01–1.80).
Chen et al. (2015) Retrospective popula‐
tion‐wide registry study 
(NSW)
2000–2008 Patients diagnosed 
with any of 5 cancers 
(N = 39,333 CRC 
patients)
ARIA+ (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Significant differences in survival identified in adjusted 
regression models: Metastatic colon cancer in Outer 
Regional areas (HR = 1.14, 1.01–1.29); and localised 
rectal cancer in Outer Regional areas (HR = 1.68, 
1.02–2.77) and for regionalised rectal cancer in Inner 
Regional (HR = 1.14, 1.002–1.30).
Log‐rank test: p < 0.05 High (15) After adjusting for gender and age, where 
significant differences were found, major 
cities tended to show the best survival, 
whereas outer regional areas tended to 
show the worst for both metastatic colon 
and localised rectal cancer.
Coory et al. 
(2013)
Retrospective population‐
wide mortality analysis 
using ABS data





Excess cause‐specific deaths and 
age‐standardised mortality ratios 
(SMRs)
For men with CRC: number of excess cancer deaths in 
regional and remote areas = 407 (95% CI, 242–576). 
SMR = 1.05 (1.02–1.09). 
For women with CRC: number of excess cancer 
deaths in regional and remote areas = 343 (95% CI, 
197–492) compared with metro areas. SMR = 1.06 
(1.02–1.10)
Significant at the 0.05 level Moderate 
(13)
There was an increased number of excess 
deaths in regional and remote areas com‐
pared to metropolitan areas. For both men 
and women, mortality rates in regional and 
remote areas were higher than rates in the 
metro population.
Cramb et al. 
(2012)
Retrospective population‐
wide registry study (QLD)
1996–2007 Patients < 90 years in 
Queensland diagnosed 
with CRC (N = 26,390)
Distance to treatment: 
<2 hr, 2–6 hr, and 6+ hr
Relative excess risk of cancer 
death (RER) within 5 years of 
diagnosis
Survival estimates: <2 hr = 64.9%; 2–6 hr = 60.6%; 
>6 hr = 59.7%. 
Adjusted RER estimates: <2 hr = 1.00; 2–6 hr = 0.99 
(0.91–1.06); >6 hr = 1.07 (0.97–1.16). 
Of the 6,019 CRC deaths within 5 years of diagnosis 
in QLD, 470 (8%) would not have occurred if there 
were no spatial inequalities in the non‐diagnostic 
survival component (after adjusting for stage, age and 
gender)
Log‐rank test: p < 0.001 High (17) Risk of death was slightly lower for patients 
travelling	2−6	hr	to	treatment	and	higher	for	
patients travelling 6+ hr to treatment com‐
pared to those travelling less than 2 hr to 
treatment (adjusting for age, gender, stage, 
distance and area disadvantage).
Hall et al. (2005) Retrospective population‐
wide data linkage study 
(WA)
1991–2001 WA residents with di‐
agnosis of invasive pri‐
mary CRC (N = 10,217)
ARIA (5 categories) Five‐year all‐cause mortality Cox regression analysis or the likelihood of death 
from any cause according to ARIA (HR, 95% CI): Very 
accessible = HR 1.00; accessible = 0.85 (0.71–1.02); 
mod accessible = 1.10 (0.90–1.34); remote = 1.19 
(0.85–1.66); very remote = 1.05 (0.71–1.54)
Not reported High (17) Residency in rural areas or admission to a 
rural hospital had no effect on the likelihood 
of death.
Hocking et al. 
(2014)
Retrospective population‐
wide data linkage study 
(SA Clinical Registry for 
Metastatic CRC)
2006–2012 SA patients with meta‐
static CRC (N = 2,289)
Postcodes within state 
capital Adelaide were 
“city” cohort; remain‐
ing postcodes were 
“rural” cohort
Median overall survival (months) Median survival: 
city = 14.6 months 
rural = 14.9 months
Log‐rank test: p = 0.18 Moderate 
(13)
No significant differences in median survival 
were noted between metropolitan and rural 
patients.
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Study Design and data source
Diagnosis 
Period Population Rural/urban definition Outcome(s) Key findings
Statistical inference of 
differences Study quality Evidence summary
Jong et al. 
(2004)*
Retrospective popula‐
tion‐wide registry study 
(NSW)
1992–1996 All patients diagnosed 
with any cancer 
(N = 132,516)
ARIA (3 categories) Relative excess risk of cancer 
death (RER) within 5 years of 
diagnosis
Five‐year adjusted RER for colon cancer (95% CI): 
highly accessible = 1.00 (ref); accessible = 1.15 
(1.05–1.25); mod accessible = 1.30 (1.04–1.63); and 
remote = 1.01 (0.61–1.68). 
Five‐year adjusted RER for rectal cancer: highly 
accessible = 1.00 (ref); accessible = 1.07 (0.94–1.21); 
mod accessible = 1.22 (0.92–1.62); and remote = 2.32 
(1.38–3.89)
Colon: p = 0.006 
Rectal: p = 0.02
High (16) After adjusting for stage at diagnosis, age, sex 
and years since diagnosis risk of death in‐
creased in accessible and moderately acces‐
sible but not remote areas for colon cancer. 
Increased risk of death was reported with 
increasing distance from highly accessible 
areas in rectal cancer. No significant differ‐
ence in models without stage of disease as 
a covariate.
Martin et al. 
(2015)
Retrospective popula‐
tion‐wide data linkage 
and registry study (Royal 
Perth Hospital—WA)
2007–2011 Patients diagnosed with 
any advanced cancer 
(N = 395 CRC)
Residential postcode: 
regional (>6,211) ver‐
sus metropolitan Perth 
(6,000–6211)
Median overall survival (months) Median survival: 
Metropolitan = 13.1 months 
Regional = 16.4 months 
HR = 1.13; 95% CI = 0.88–1.45
Log‐rank test p = 0.32 Moderate 
(11)
No significant difference in median survival 
for metropolitan versus regional patients 
was noted for colorectal cancer.
Roder et al. 
(2015)
Retrospective population‐
wide registry study (SA)
1980–2010 South Australian CRC 
patients (N = 9,098)
Postcode of resi‐
dence: metro or 
non‐metropolitan
Cause‐specific 5 year relative 
survival rates (%)
Survival did not vary by place of residence (Cox pro‐
portional hazards regression analyses not presented)
Not significant (p > 0.001) High (16) No significant difference in survival rates 
between metropolitan and non‐metropoli‐
tan areas.
Singla et al. 
(2014)
Retrospective cohort 
study using South 
Australian Clinical 
Registry for Metastatic 
Colorectal Cancer
2006 –2012 Patients with metastatic 
CRC (N = 2,001)
ASGC (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Cox proportional hazards model (HR, 95% CI, p): 
major city = 1.00; inner regional = 0.65 (0.32–1.32, 
0.235); outer regional = 1.50 (0.78–2.90, 0.225); 
remote = 1.43 (0.48–4.29, 0.522)
Not significant (p > 0.05) High (14) No significant difference in survival for meta‐
static colorectal cancer across regions.
Tervonen et al. 
(2017)
Retrospective popula‐
tion‐wide registry study 
(NSW)
1980 –2008 Patients with CRC 
(N = 101,402)
ARIA+ (3 categories) Relative risk of cancer death Competing risk regression model (Sub Hazard Ratio, 
95% CI): 
Major cities = 1.00 
Inner regional = 1.02, 0.99–1.05 
Outer regional/remote = 1.12, 1.08–1.17
95% CIs High (17) Compared with major cities, living in outer 
regional/ remote areas was generally associ‐
ated with a slightly increased risk of cancer 




wide registry study (SA)
1977–1993 All cancer patients in SA 
(N = 82,000 total—no 
breakdown of CRC 
cases)
Postcode at diagnosis: 
Adelaide city = urban. 
Rest of state = rural
Cause‐specific 5 year relative 
survival rates (%)
Colon cancer survival rates (SE): 
urban = 54.0% (±0.9); rural = 49.3% (±1.6) 
Rectal cancer survival rates: 
urban = 55.5% (±1.2); rural = 50.4% (±2.0)
Considered statistically signifi‐




Survival rates from both colon and rectal can‐
cer were significantly higher in urban areas 











tion‐wide study (ABS 
mortality database)
2002–2004 All CRC patients ASGC (5 categories) Standardised cause‐specific mor‐
tality ratio (SMR)
SMR: 1.10* inner regional, 1.10* outer regional, 0.86 
in remote areas, and 0.64* in very remote areas, 
compared to major cities. 
Excess death: inner regional = 95, outer re‐
gional	=	43,	remote	=	−7,	very	remote	=	−8.
*Considered significant as p 
= <0.05
High (15) Death rates in regional areas were 10% 
higher than in major centres. Death rates 
in remote areas were lower, but not signifi‐






wide study (Australian 
Cancer Database)
2006–2010 All CRC patients ASGC (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Survival based on area (95% CI): 
major cities = 67.2% (66.5–67.8); inner re‐
gional = 64.9% (63.8–66.0); outer regional = 62.6% 
(60.9–64.3); remote = 62.8 (58.3–67.1).
95% CIs High (14) Survival significantly higher in major cities 







wide study (Australian 
Cancer Database)
2010–2014 All CRC patients ARIA+ (5 categories) Age‐standardised mortality rate 
(ASR) and rate ratio (RR)
ASR: Major cities = 15.8; Inner regional = 15.8; Outer 
regional = 16.3; Remote = 14.1; Very remote = 10.9 
RR (relative to all of Australia): Major cities = 0.98; 
Inner regional = 1.03; Outer regional = 1.06; 
Remote = 0.93; Very remote = 0.73
 High (14) Compared with major cities, people living 
in remote and very remote areas have an 





tion‐wide registry study 
(NSW)
2005–2009 All cancer 
patients aged 
15–100 years
ARIA (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Colon cancer 5‐year RS (95% CI): major city = 67.9 
(66.8–69.1); inner regional = 65.6 (63.7–67.6); 
outer regional = 62.6 (59.1–65.6); remote/very 
remote = 65.1 (51.0–77.6). 
Rectal cancer 5‐year RS: major city = 67.3 (65.8–
68.7); inner regional = 64.8 (62.4–67.2); outer re‐
gional = 63.5 (59.2–67.7); remote/very remote = 72.1 
(54.2–85.9).
95% CIs High (15) Based on 95% CI the current authors note 
significantly lower survival rate for outer 
regional compared to major city for colon 
cancer and no significant differences for 
rectal cancer.
(Continues)
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Study Design and data source
Diagnosis 
Period Population Rural/urban definition Outcome(s) Key findings
Statistical inference of 
differences Study quality Evidence summary
Jong et al. 
(2004)*
Retrospective popula‐
tion‐wide registry study 
(NSW)
1992–1996 All patients diagnosed 
with any cancer 
(N = 132,516)
ARIA (3 categories) Relative excess risk of cancer 
death (RER) within 5 years of 
diagnosis
Five‐year adjusted RER for colon cancer (95% CI): 
highly accessible = 1.00 (ref); accessible = 1.15 
(1.05–1.25); mod accessible = 1.30 (1.04–1.63); and 
remote = 1.01 (0.61–1.68). 
Five‐year adjusted RER for rectal cancer: highly 
accessible = 1.00 (ref); accessible = 1.07 (0.94–1.21); 
mod accessible = 1.22 (0.92–1.62); and remote = 2.32 
(1.38–3.89)
Colon: p = 0.006 
Rectal: p = 0.02
High (16) After adjusting for stage at diagnosis, age, sex 
and years since diagnosis risk of death in‐
creased in accessible and moderately acces‐
sible but not remote areas for colon cancer. 
Increased risk of death was reported with 
increasing distance from highly accessible 
areas in rectal cancer. No significant differ‐
ence in models without stage of disease as 
a covariate.
Martin et al. 
(2015)
Retrospective popula‐
tion‐wide data linkage 
and registry study (Royal 
Perth Hospital—WA)
2007–2011 Patients diagnosed with 
any advanced cancer 
(N = 395 CRC)
Residential postcode: 
regional (>6,211) ver‐
sus metropolitan Perth 
(6,000–6211)
Median overall survival (months) Median survival: 
Metropolitan = 13.1 months 
Regional = 16.4 months 
HR = 1.13; 95% CI = 0.88–1.45
Log‐rank test p = 0.32 Moderate 
(11)
No significant difference in median survival 
for metropolitan versus regional patients 
was noted for colorectal cancer.
Roder et al. 
(2015)
Retrospective population‐
wide registry study (SA)
1980–2010 South Australian CRC 
patients (N = 9,098)
Postcode of resi‐
dence: metro or 
non‐metropolitan
Cause‐specific 5 year relative 
survival rates (%)
Survival did not vary by place of residence (Cox pro‐
portional hazards regression analyses not presented)
Not significant (p > 0.001) High (16) No significant difference in survival rates 
between metropolitan and non‐metropoli‐
tan areas.
Singla et al. 
(2014)
Retrospective cohort 
study using South 
Australian Clinical 
Registry for Metastatic 
Colorectal Cancer
2006 –2012 Patients with metastatic 
CRC (N = 2,001)
ASGC (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Cox proportional hazards model (HR, 95% CI, p): 
major city = 1.00; inner regional = 0.65 (0.32–1.32, 
0.235); outer regional = 1.50 (0.78–2.90, 0.225); 
remote = 1.43 (0.48–4.29, 0.522)
Not significant (p > 0.05) High (14) No significant difference in survival for meta‐
static colorectal cancer across regions.
Tervonen et al. 
(2017)
Retrospective popula‐
tion‐wide registry study 
(NSW)
1980 –2008 Patients with CRC 
(N = 101,402)
ARIA+ (3 categories) Relative risk of cancer death Competing risk regression model (Sub Hazard Ratio, 
95% CI): 
Major cities = 1.00 
Inner regional = 1.02, 0.99–1.05 
Outer regional/remote = 1.12, 1.08–1.17
95% CIs High (17) Compared with major cities, living in outer 
regional/ remote areas was generally associ‐
ated with a slightly increased risk of cancer 




wide registry study (SA)
1977–1993 All cancer patients in SA 
(N = 82,000 total—no 
breakdown of CRC 
cases)
Postcode at diagnosis: 
Adelaide city = urban. 
Rest of state = rural
Cause‐specific 5 year relative 
survival rates (%)
Colon cancer survival rates (SE): 
urban = 54.0% (±0.9); rural = 49.3% (±1.6) 
Rectal cancer survival rates: 
urban = 55.5% (±1.2); rural = 50.4% (±2.0)
Considered statistically signifi‐




Survival rates from both colon and rectal can‐
cer were significantly higher in urban areas 











tion‐wide study (ABS 
mortality database)
2002–2004 All CRC patients ASGC (5 categories) Standardised cause‐specific mor‐
tality ratio (SMR)
SMR: 1.10* inner regional, 1.10* outer regional, 0.86 
in remote areas, and 0.64* in very remote areas, 
compared to major cities. 
Excess death: inner regional = 95, outer re‐
gional	=	43,	remote	=	−7,	very	remote	=	−8.
*Considered significant as p 
= <0.05
High (15) Death rates in regional areas were 10% 
higher than in major centres. Death rates 
in remote areas were lower, but not signifi‐






wide study (Australian 
Cancer Database)
2006–2010 All CRC patients ASGC (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Survival based on area (95% CI): 
major cities = 67.2% (66.5–67.8); inner re‐
gional = 64.9% (63.8–66.0); outer regional = 62.6% 
(60.9–64.3); remote = 62.8 (58.3–67.1).
95% CIs High (14) Survival significantly higher in major cities 







wide study (Australian 
Cancer Database)
2010–2014 All CRC patients ARIA+ (5 categories) Age‐standardised mortality rate 
(ASR) and rate ratio (RR)
ASR: Major cities = 15.8; Inner regional = 15.8; Outer 
regional = 16.3; Remote = 14.1; Very remote = 10.9 
RR (relative to all of Australia): Major cities = 0.98; 
Inner regional = 1.03; Outer regional = 1.06; 
Remote = 0.93; Very remote = 0.73
 High (14) Compared with major cities, people living 
in remote and very remote areas have an 





tion‐wide registry study 
(NSW)
2005–2009 All cancer 
patients aged 
15–100 years
ARIA (4 categories) Cause‐specific 5 year relative 
survival rates (%)
Colon cancer 5‐year RS (95% CI): major city = 67.9 
(66.8–69.1); inner regional = 65.6 (63.7–67.6); 
outer regional = 62.6 (59.1–65.6); remote/very 
remote = 65.1 (51.0–77.6). 
Rectal cancer 5‐year RS: major city = 67.3 (65.8–
68.7); inner regional = 64.8 (62.4–67.2); outer re‐
gional = 63.5 (59.2–67.7); remote/very remote = 72.1 
(54.2–85.9).
95% CIs High (15) Based on 95% CI the current authors note 
significantly lower survival rate for outer 
regional compared to major city for colon 
cancer and no significant differences for 
rectal cancer.
(Continues)
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3.4 | Measures of survival
The reviewed studies report survival outcomes using a variety of dif‐
ferent values including odds ratios (OR), hazard ratios (HR), standard 
mortality ratios (SMR) and relative excess risk ratios (RER). Subtle dif‐
ferences exist in the calculation of each ratio (see Table 3); however, 
their interpretation is analogous. That is, values lower than 1 represent 
a lower chance of an event occurring (i.e. death or survival), while val‐
ues higher than 1 represent a higher chance of the event occurring.
3.4.1 | Survival findings
Of the 23 studies that investigated CRC survival disparities, 16 (69%) 
reported evidence that living outside of a major city in Australia is 
Study Design and data source
Diagnosis 
period Population Rural/urban definition Outcome(s) Key findings Tests of significance Study quality Evidence summary
Cramb et al. 
(2011)




1998–2007 All cancers 
diagnosed in 
Queensland
ARIA+ (4 categories) Smoothed relative excess risk 
(RER) by sex within five years of 
diagnosis
Males RER (95% CI): major city = 94.2 (91.1–97.5), 
inner regional = 103.3 (98.0–108.7), outer re‐
gional = 113.1 (107.6–119.1), remote = 116.9 
(108.7–126.0) 
Females RER (95% CI): major city = 96.1 (92.4–
100.2), inner regional = 102.8 (97.1–108.7), outer 
regional = 110.4 (103.9–117.4), remote = 112.0 
(103.0–122.7)
“Strong” (p < 0.01) based on 





Risk of CRC death increased with increasing 
remoteness for both males and females. 
Survival tended to be lower than the 
Queensland average in more rural, remote 
or disadvantaged areas.




1995–2008 Colorectal cancer 
patients aged 
0–74 years
ASGC (3 categories) Cause‐specific 5 year relative 
survival rates (%), age‐standard‐
ised mortality rates (ASR) and 
Rate Ratios




Adelaide = 13.2; non‐metro SA = 10.5 
RR = 1.27
95% CIs Moderate 
(13)
Based on 95% CI the current authors 
note that between 1995 and 2008 inner 
regional and more remote residents had a 
significantly higher risk of death that those 
in Adelaide City. Recent data (2003–2007) 
suggests that “premature” mortality rates 




tion‐wide cohort study 
(Queensland Oncology 
Repository)
2012 All colorectal 
cancer patients 
diagnosed in 
2012 (N = 2,788)
ASGC (4 categories) 2 year crude survival from diagno‐
sis and RRs calculated by current 
authors
Colon cancer survival rates: major city = 83%, inner 
regional = 82%, outer regional = 82%, remote/very 
remote = 77%. 
RR: Major City (ref); Inner regional: RR = 1.05 
(0.082–1.37); Outer regional: RR = 1.43 (0.76–1.43); 
Remote/Very Remote: RR 1.37 (0.71–2.66) 
Rectal cancer survival rates: major city = 89%, inner 
regional = 90%, outer regional = 84%, remote/very 
remote = 79%. 
RR: Major City (ref); Inner regional: RR 0.90 (0.51–
1.56); Outer regional: RR 0.50 (0.20–1.22); Remote: 
RR 1.15 (0.30–4.32)




Based on 95% CI the current authors note 
no significant differences in survival by 





tion‐wide registry study 
(WA)
2014 All new cases of 
cancer recorded 
in WA in 2014
Two WA metropolitan Area 
Health Service (North and 
South Metro AHS) and 
seven WA country health 
service (Kimberley, Pilbara, 
Midwest, Wheatbelt, 
Goldfields, Great Southern 
& South West)
Age‐standardised 1‐ year mortality 
rate by sex (ASR)
Males ASR (95% CI): 
country = 8.7 (6.0–11.4) 
metro = 11.6 (9.9–13.3) 
Females ASR: 
country = 9.1 (6.4–11.8) 
metro = 7.1 (5.8–8.4)
95% CIs Moderate 
(13)
Based on 95% CI the current authors note no 







tion‐wide registry study 
(Victoria)
1986–2010 All persons with a 
first diagnosis of 
cancer in Victoria
Metropolitan is defined as 
the three metropolitan 
Integrated Cancer Service 
(ICS) regions—Southern, 
Western & Central and 
North‐Eastern. The rest 
of Victoria includes the 
five rural ICS regions—
Barwon, Grampians, 
Loddon‐Mallee, Hume and 
Gippsland.
Cause‐specific 5 year relative 
survival rates (%)
5‐year survival rate (95% CI): 
Melbourne = 67% (66–68) 
rest of Victoria 61% (60–62)
p < 0.01 High (16) CRC survival was significantly higher in 
residents of Melbourne than those from the 
rest of the state of Victoria
Abbreviations: ARIA, Accessibility/Remoteness Index of Australia; ASGC, Australian Standard Geographical Classification; NSW, New South  
Wales; QLD, Queensland; SA, South Australia; WA, Western Australia.
*Included in both Table 1 (survival differences) and Table 2 (stage at diagnosis) 
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associated with lower survival following CRC. Of the 12 studies that 
reported a cause‐specific five‐year survival analysis, 11 (91%) re‐
ported significantly poorer survival outside of metropolitan areas, 
and four of five studies (80%) that reported standardised mortality 
rates also reported worse survival in non‐metropolitan areas. Four 
studies reported on relative risk and found increased risk of death 
from CRC with increasing remoteness. Five reviewed studies did not 
find significant geographical differences; two studies that reported 
on median survival length, one study that covered a shorter survival 
timeframe and was not age‐adjusted, and two studies that reported 
on all‐cause mortality. The majority of studies reviewed controlled 
for factors that have been found to impact survival including age 




period Population Rural/urban definition Outcome(s) Key findings Tests of significance Study quality Evidence summary
Cramb et al. 
(2011)




1998–2007 All cancers 
diagnosed in 
Queensland
ARIA+ (4 categories) Smoothed relative excess risk 
(RER) by sex within five years of 
diagnosis
Males RER (95% CI): major city = 94.2 (91.1–97.5), 
inner regional = 103.3 (98.0–108.7), outer re‐
gional = 113.1 (107.6–119.1), remote = 116.9 
(108.7–126.0) 
Females RER (95% CI): major city = 96.1 (92.4–
100.2), inner regional = 102.8 (97.1–108.7), outer 
regional = 110.4 (103.9–117.4), remote = 112.0 
(103.0–122.7)
“Strong” (p < 0.01) based on 





Risk of CRC death increased with increasing 
remoteness for both males and females. 
Survival tended to be lower than the 
Queensland average in more rural, remote 
or disadvantaged areas.




1995–2008 Colorectal cancer 
patients aged 
0–74 years
ASGC (3 categories) Cause‐specific 5 year relative 
survival rates (%), age‐standard‐
ised mortality rates (ASR) and 
Rate Ratios




Adelaide = 13.2; non‐metro SA = 10.5 
RR = 1.27
95% CIs Moderate 
(13)
Based on 95% CI the current authors 
note that between 1995 and 2008 inner 
regional and more remote residents had a 
significantly higher risk of death that those 
in Adelaide City. Recent data (2003–2007) 
suggests that “premature” mortality rates 




tion‐wide cohort study 
(Queensland Oncology 
Repository)
2012 All colorectal 
cancer patients 
diagnosed in 
2012 (N = 2,788)
ASGC (4 categories) 2 year crude survival from diagno‐
sis and RRs calculated by current 
authors
Colon cancer survival rates: major city = 83%, inner 
regional = 82%, outer regional = 82%, remote/very 
remote = 77%. 
RR: Major City (ref); Inner regional: RR = 1.05 
(0.082–1.37); Outer regional: RR = 1.43 (0.76–1.43); 
Remote/Very Remote: RR 1.37 (0.71–2.66) 
Rectal cancer survival rates: major city = 89%, inner 
regional = 90%, outer regional = 84%, remote/very 
remote = 79%. 
RR: Major City (ref); Inner regional: RR 0.90 (0.51–
1.56); Outer regional: RR 0.50 (0.20–1.22); Remote: 
RR 1.15 (0.30–4.32)




Based on 95% CI the current authors note 
no significant differences in survival by 





tion‐wide registry study 
(WA)
2014 All new cases of 
cancer recorded 
in WA in 2014
Two WA metropolitan Area 
Health Service (North and 
South Metro AHS) and 
seven WA country health 
service (Kimberley, Pilbara, 
Midwest, Wheatbelt, 
Goldfields, Great Southern 
& South West)
Age‐standardised 1‐ year mortality 
rate by sex (ASR)
Males ASR (95% CI): 
country = 8.7 (6.0–11.4) 
metro = 11.6 (9.9–13.3) 
Females ASR: 
country = 9.1 (6.4–11.8) 
metro = 7.1 (5.8–8.4)
95% CIs Moderate 
(13)
Based on 95% CI the current authors note no 







tion‐wide registry study 
(Victoria)
1986–2010 All persons with a 
first diagnosis of 
cancer in Victoria
Metropolitan is defined as 
the three metropolitan 
Integrated Cancer Service 
(ICS) regions—Southern, 
Western & Central and 
North‐Eastern. The rest 
of Victoria includes the 
five rural ICS regions—
Barwon, Grampians, 
Loddon‐Mallee, Hume and 
Gippsland.
Cause‐specific 5 year relative 
survival rates (%)
5‐year survival rate (95% CI): 
Melbourne = 67% (66–68) 
rest of Victoria 61% (60–62)
p < 0.01 High (16) CRC survival was significantly higher in 
residents of Melbourne than those from the 
rest of the state of Victoria
Abbreviations: ARIA, Accessibility/Remoteness Index of Australia; ASGC, Australian Standard Geographical Classification; NSW, New South  
Wales; QLD, Queensland; SA, South Australia; WA, Western Australia.
*Included in both Table 1 (survival differences) and Table 2 (stage at diagnosis) 
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The pattern of results was not consistent across States and 
Territories or across studies applying different geographical classi‐
fications. All four studies from New South Wales showed significant 
geographical disparity in survival rates with poorer survival in non‐
metropolitan areas; however, these findings differed when colon 
and rectal cancer were analysed separately (Cancer Institute NSW, 
2018; Chen et al., 2015; Jong et al., 2004; Tervonen et al., 2017). Four 
of five studies in Queensland populations showed poorer survival 
with increasing distance from a major city (Baade, Dasgupta, Aitken, 
& Turrell, 2011a, 2013; Cramb, Mengersen, & Baade, 2011; Cramb, 
Mengersen, Turrell, & Baade, 2012); however, none of the studies 
conducted in Western Australia (N = 3) found significant geographic 
disparity (Hall et al., 2005; Martin et al., 2015; Threlfall & Thompson, 
2015), and mixed results were evident in South Australian samples 
(Beckmann et al., 2016; Hocking et al., 2014; PHIDU, 2012; Roder 
et al., 2015; Singla, Broadbridge, Mittinty, Beeke, & Maddern, 2014; 
Wilkinson & Cameron, 2004) and using national data (Australian 
Institute of Health & Welfare, 2007, 2012, 2017b; Coory, Ho, & 
Jordan, 2013). Fifteen studies utilised standard geographical classi‐
fication structures such as the ASGC and the ARIA, using between 
two and five categories. Twelve of these (80%) reported disparities 
in CRC survival across geographic locations, however, for eight of 
these studies geographic variations were not linear in nature (i.e. did 
not exhibit poorer survival as a linear function of increasing rurality). 
For instance, there was a trend for the lowest survival rates to be 
observed for inner and outer regional areas rather than remote or 
very remote areas.
The majority of included studies utilised data from approximately 
10 or more years ago (N = 19/23, 82%), with 13 of those studies re‐
porting significantly poorer survival rates in non‐metropolitan loca‐
tions. Of the studies utilising newer data (<10 years old), one using 
national data and one using data from New South Wales reported 
significant disparities in survival, while two state‐specific studies 
from South Australia and Western Australia reported no significant 
geographic variations. This may indicate that geographical trends in 
CRC survival are changing over time.
TA B L E  2   Characteristics of included studies (geographic variations in CRC stage at diagnosis)
Study Design
Diagnosis 
period Population Rural/urban definition Outcome(s) Key findings





Baade et al. 
(2011b)
Retrospective population‐
wide registry study (QLD)
1996–2007 Patients aged 
20–79 years diagnosed 
with invasive stage I‐IV 
CRC (N = 18,561)
ARIA + (4 categories) Dichotomous outcome: “localised” 
versus “regional and distal”
Probability of experiencing advanced stage CRC 
(Odds Ratio, 95% CI): major city = 1.00 (ref); inner 
regional = 1.09 (1.01–1.19); outer regional = 1.11 
(1.01–1.22); remote/very remote = 1.00 
(0.85–1.16)
Analyses stratified by cancer site showed that 
remoteness was significant for colon cancer 
(p = 0.048) but not for rectal cancer (p = 0.873)
Significance tested using 
Z test:
P‐value = 0.045
High (17) Individuals from inner regional and outer regional 
areas had significantly higher rates of advanced 
CRC compared to major cities, while remote areas 
had similar rates, after adjusting for sex, age, year of 





wide registry study (SA)
2003–2008 Cases of CRC aged 
50–79 years (N = 4,362)
ARIA (5 categories) Stage at diagnosis (ordinal outcome, 
A to D)
Adjusted odds ratio for factors associated with later 
stage at diagnosis (OR, 95% CI): Inner urban = 1.00 
(ref); outer urban = 0.89 (0.74–1.07); rural = 0.99 
(0.83–1.16); remote = 0.99 (0.77–1.26)
P values derived from 
ordinal logistic regression 
(all p > 0.05)
High (16) Distribution of stage at diagnosis did not differ by 
remoteness of residence in unadjusted analyses. 
Multivariate analysis showed that stage at diagnosis 




wide data linkage study 
(NSW cancer registry and 
45 and Up Study data)
2006–2009 Patients diagnosed with 
any cancer (N = 890 
CRC cases)
“Farm residents” were 
defined as those who 
indicated that they 
lived in a “house on 
farm”
Rural “non‐farm” and 
urban residents were 
defined using ARIA+ (2 
categories)
Degree of spread: (dichotomous out‐
come Stage 1, “early stage” versus 
Stage 2 or above “later stage”
Adjusted odds ratio for stage 2 + CRC in men 
(95% CI): Farm = 1.00 ref, Rural non‐farm = 0.45 
(0.19–1.07), urban = 0.49 (0.21–1.17)
Adjusted odds ratio for stage 2 + CRC in women 
(95% CI): Farm = 1.00 ref, Rural non‐farm = 1.21 
(0.47–3.09), urban = 0.92 (0.36–2.35)
P values derived from 
ordinal logistic regression 
(all p > 0.25)
High (14) Differences in stage of cancer diagnosis between rural 
and urban were not statistically significant; however, 
farm men had twice the odds of either non‐farm rural 
or urban men of being diagnosed at later stage CRC.
Jong et al., 
2004*
Retrospective population‐
based cohort using NSW 
cancer registry
1992–1996 Patients diagnosed 
with any cancer 
(N = 132,516)
ARIA (3 categories) Spread of cancer at diagnosis (or‐
dinal outcome, localised, regional, 
distant)
Ordinal logistic regression adjusting for age and 
sex to compare spread of cancer between highly 
accessible areas and the remaining areas.
Results not presented.
p > 0.05 High (17) No significant difference in spread of CRC at diagnosis.
Study Design and data source
Diagnosis 







using NSW colorectal 
cancer care survey
2000 CRC patients 
(N = 3,095)
ARIA (3 categories) Stage at diagnosis: Localised (Submucosa and Beyond wall), 
Regional, and Distal
Mean stage at diagnosis (SD):
highly accessible (M = 2.33, SD = 1.07); accessible 
(M = 2.31, SD = 1.04); moderately accessible/
remote (M = 2.31, SD = 1.13).
Remoteness did not predict advanced stage at 
diagnosis (OR = 0.91, 29% CI = 0.73–1.14)
No statistical comparison 
undertaken, current au‐
thors evaluated 95% CIs
Moderate 
(11)
Based on tabled frequency data provided, the current 
authors found no significant differences between 
mean stage of diagnosis across regions. Highest 
percentage of advanced cancer in remote areas was 
not significant.
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3.5 | Cancer staging
Cancer stage refers to the extent of disease at diagnosis, defined ac‐
cording to established criteria. For this review, CRC stage at diagnosis is 
considered within four categories: Stage I (localised), where the cancer 
is limited to the site of origin; Stage II (regional), where the cancer has 
spread beyond the initial site, often to the nearest lymph nodes; Stage 
III (distal), where the cancer has spread more extensively; and Stage 
IV, where the cancer has spread to distant organs (metastatic disease).
3.5.1 | Stage at diagnosis findings
Only one of five reviewed studies reported disparities in stage at 
diagnosis, with individuals from regional areas showing significantly 
higher rates of advanced CRC compared to major cities, while re‐
mote areas had similar rates. However, these findings applied to 
colon cancer only and pertained to a Queensland only sample from 
1996–2007 (Baade et al., 2011b).
4  | DISCUSSION
From the studies reviewed, there is strong and consistent evidence 
that in Australia, non‐metropolitan CRC patients have significantly 
lower five‐year survival compared to patients living in metropolitan 
areas. Insufficient evidence was available to draw meaningful con‐
clusions about geographic disparities in stage at diagnosis for CRC 
patients. There are several lessons to be learned from the available 
data that warrant particular attention in understanding geographical 
variations, and in informing the direction and priorities for future re‐
search. In particular, these data provide important information about 
the current state of research in the area and improvements that can 
be made, with relevance to both Australia and internationally.
Findings from research conducted outside of Australia suggest 
that geographic disparities in survival may be explained by demo‐
graphic factors such as ethnicity and socioeconomic status (Feller et 
al., 2018; Henry, Niu, & Boscoe, 2009; Launoy, Le Coutour, Gignoux, 
Pottier, & Dugleux, 1992; Singh, Williams, Siahpush, & Mulhollen, 
TA B L E  2   Characteristics of included studies (geographic variations in CRC stage at diagnosis)
Study Design
Diagnosis 
period Population Rural/urban definition Outcome(s) Key findings





Baade et al. 
(2011b)
Retrospective population‐
wide registry study (QLD)
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ARIA + (4 categories) Dichotomous outcome: “localised” 
versus “regional and distal”
Probability of experiencing advanced stage CRC 
(Odds Ratio, 95% CI): major city = 1.00 (ref); inner 
regional = 1.09 (1.01–1.19); outer regional = 1.11 
(1.01–1.22); remote/very remote = 1.00 
(0.85–1.16)
Analyses stratified by cancer site showed that 
remoteness was significant for colon cancer 
(p = 0.048) but not for rectal cancer (p = 0.873)
Significance tested using 
Z test:
P‐value = 0.045
High (17) Individuals from inner regional and outer regional 
areas had significantly higher rates of advanced 
CRC compared to major cities, while remote areas 
had similar rates, after adjusting for sex, age, year of 





wide registry study (SA)
2003–2008 Cases of CRC aged 
50–79 years (N = 4,362)
ARIA (5 categories) Stage at diagnosis (ordinal outcome, 
A to D)
Adjusted odds ratio for factors associated with later 
stage at diagnosis (OR, 95% CI): Inner urban = 1.00 
(ref); outer urban = 0.89 (0.74–1.07); rural = 0.99 
(0.83–1.16); remote = 0.99 (0.77–1.26)
P values derived from 
ordinal logistic regression 
(all p > 0.05)
High (16) Distribution of stage at diagnosis did not differ by 
remoteness of residence in unadjusted analyses. 
Multivariate analysis showed that stage at diagnosis 




wide data linkage study 
(NSW cancer registry and 
45 and Up Study data)
2006–2009 Patients diagnosed with 
any cancer (N = 890 
CRC cases)
“Farm residents” were 
defined as those who 
indicated that they 
lived in a “house on 
farm”
Rural “non‐farm” and 
urban residents were 
defined using ARIA+ (2 
categories)
Degree of spread: (dichotomous out‐
come Stage 1, “early stage” versus 
Stage 2 or above “later stage”
Adjusted odds ratio for stage 2 + CRC in men 
(95% CI): Farm = 1.00 ref, Rural non‐farm = 0.45 
(0.19–1.07), urban = 0.49 (0.21–1.17)
Adjusted odds ratio for stage 2 + CRC in women 
(95% CI): Farm = 1.00 ref, Rural non‐farm = 1.21 
(0.47–3.09), urban = 0.92 (0.36–2.35)
P values derived from 
ordinal logistic regression 
(all p > 0.25)
High (14) Differences in stage of cancer diagnosis between rural 
and urban were not statistically significant; however, 
farm men had twice the odds of either non‐farm rural 
or urban men of being diagnosed at later stage CRC.
Jong et al., 
2004*
Retrospective population‐
based cohort using NSW 
cancer registry
1992–1996 Patients diagnosed 
with any cancer 
(N = 132,516)
ARIA (3 categories) Spread of cancer at diagnosis (or‐
dinal outcome, localised, regional, 
distant)
Ordinal logistic regression adjusting for age and 
sex to compare spread of cancer between highly 
accessible areas and the remaining areas.
Results not presented.
p > 0.05 High (17) No significant difference in spread of CRC at diagnosis.
Study Design and data source
Diagnosis 







using NSW colorectal 
cancer care survey
2000 CRC patients 
(N = 3,095)
ARIA (3 categories) Stage at diagnosis: Localised (Submucosa and Beyond wall), 
Regional, and Distal
Mean stage at diagnosis (SD):
highly accessible (M = 2.33, SD = 1.07); accessible 
(M = 2.31, SD = 1.04); moderately accessible/
remote (M = 2.31, SD = 1.13).
Remoteness did not predict advanced stage at 
diagnosis (OR = 0.91, 29% CI = 0.73–1.14)
No statistical comparison 
undertaken, current au‐
thors evaluated 95% CIs
Moderate 
(11)
Based on tabled frequency data provided, the current 
authors found no significant differences between 
mean stage of diagnosis across regions. Highest 
percentage of advanced cancer in remote areas was 
not significant.
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2012). In addition, several other factors may be at play including 
quality of rural services accessed, the availability of private facilities, 
or differences in emergency admissions that contribute to geograph‐
ical disparity in CRC survival rather than remoteness itself (Baade et 
al., 2011b; Wan, Zhan, Lu, & Tiefenbacher, 2012). For instance, sur‐
geon expertise and hospital volume both influence CRC outcomes 
(Beckmann, Moore, Wattchow, Young, & Roder, 2016; Harmon et al., 
1999; Hodgson, Fuchs, & Ayanian, 2001). Patients living in regional 
areas may access local, lower volume, public hospitals while patients 
who receive treatment in a metropolitan area have access to a vari‐
ety of providers. A more thorough understanding of the main causes 
of geographic disparity, above and beyond location and including 
other demographic contributors, will aid future service delivery 
models and procedures.
The National Bowel Cancer Screening Program (NBCSP) was 
introduced in Australia in 2006, with full implementation of the 
programme expected in 2020. All reviewed studies investigating 
stage at diagnosis were conducted well before this implementation. 
Thus, the majority of participants sampled in this review would not 
have been exposed to population‐wide screening. The majority of 
these studies reported that stage at diagnosis did not differ across 
geographic locations (Armstrong, O’Connell, Leong, Spigelman, 
& Armstrong, 2004; Baade et al., 2011b; Beckmann et al., 2016; 
Depczynski, Dobbins, Armstrong, & Lower, 2018; Jong et al., 2004). 
Based on this, suggestions that late diagnosis may explain disparities 
in CRC survival and outcomes are not strongly supported. It may be 
that geographic disparity in stage of CRC diagnosis itself does not 
exist, or alternatively that the current evidence does not allow us to 
reach this conclusion. Many countries worldwide have adopted pop‐
ulation‐level CRC screening (Swan, Siddiqui, & Myers, 2012), with 
findings suggesting that early detection through screening can re‐
duce mortality (Hewitson, Glasziou, Watson, Towler, & Irwig, 2008). 
However, there are insufficient data to determine whether screening 
has an effect on subsequent stage at diagnosis differentially across 
various geographic locations; largely because of different practices 
in collecting and defining stage data in international cancer regis‐
tries (Walters et al., 2013). Future research needs to focus on inves‐
tigating other factors that might lead to regional disparity in survival, 
as well as monitor geographic disparities in stage at diagnosis with 
population‐level data collected from the beginning of screening pro‐
grammes onwards. It is important that all data relating to stage at 
diagnosis and survival of CRC are collected, analysed and reported 
in a standardised manner, in order to produce statistics that are com‐
parable across time points.
Several studies analysed survival and stage at diagnosis sepa‐
rately for colon and rectal cancer, often reporting significant find‐
ings only for one cancer type. This suggests that studies analysing 
data on CRC as a whole may miss important differences. This is 
supported by research outside of Australia which suggests that 
differences in survival and stage at diagnosis in rural areas may dif‐
fer according to location of the tumour (Feller et al., 2018; Hines 
& Markossian, 2012). As Australian National Health and Medical 
Research Council guidelines for the clinical management of CRC 
provide different recommendations for colon and rectal cancer, ac‐
cess to chemotherapy services or radiotherapy facilities may have 
a differential impact on patients living in rural areas depending on 
their diagnosis. The reviewed studies do not provide clinical infor‐
mation on treatment, thus caution is warranted in interpreting the 
current findings. Access to screening and appropriate treatments 
may be an important indicator of survival from CRC and thus, up‐
to‐date comprehensive data are required to fully understand geo‐
graphic disparities in CRC survival and stage at diagnosis.
Reviewed studies came from several different Australian 
states, often with varied findings. Each state has a different pop‐
ulation distribution, climate and health system, making compari‐
sons between states difficult. For instance, compared with other 
Australian states, Queensland has one of the highest proportions 
of Indigenous residents, and the highest decentralised population 
Ratio value Interpretation
Odds ratio (OR) ORs represent the chance of an event occurring (usually death, 
but can represent survival) based on various other factors. It 
assumes all data to be recorded at the same time point. In the 





SMRs represent the ratio of observed deaths in the study group 
to expected deaths in the general population. Similar to the 
calculation for ORs, SMRs are calculated as follows: 
D÷Sforregional
D÷Sforgeneralpopulation
Hazard ratio (HR) HRs represent and OR at a given point in time. That is, an HR 
value is the times an event occurs more frequently per unit of 
time (e.g. 5 years since diagnosis)
Relative excess risk (RER 
or ERR)
RERs is the difference between two relative risk ratios (RR) 
represent the excess risk of an event occurring between two 










Abbreviations: D = death, S = survival.
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on the mainland with 52% of the population living outside of the 
capital city (Australian Bureau Statistics, 2016; Australian Institute 
of Health & Welfare, 2015). International research suggests that 
advanced cancer is more likely to be diagnosed among Indigenous 
populations compared with Caucasian, and among persons living 
in low socioeconomic areas (Condon, Barnes, Armstrong, Selva‐
Nayagam, & Elwood, 2005; Henry et al., 2009; Tervonen et al., 
2016). In addition, studies in the United States (McLafferty & 
Wang, 2009; Parikh‐Patel, Bates, & Campleman, 2006), Scotland 
(Campbell et al., 2001) and Switzerland (Feller et al., 2018) have re‐
ported that geographic variability in stage at diagnosis of CRC may 
reflect the different population compositions in regional areas such 
as lower socioeconomic and larger indigenous populations, as well 
as access and availability of health services. Thus, there is a complex 
relationship between the factors that make rural and regional areas 
unique and potentially influence cancer survival, and which has yet 
to be thoroughly explored.
4.1 | Strengths and limitations
Although the current review shares some overlap with a previous 
systematic review (Ireland et al., 2017), it captures data from an 
additional five government reports, two state non‐profit cancer 
organisation reports, and two peer‐reviewed papers published 
since 2017. These nine additional documents make up 35% of the 
sample of the current review. Given the rich data collected by 
state and national government agencies relating to survival and 
stage of diagnosis, the current review provides a more cohesive 
picture of this specific sub‐topic, thus providing an additional con‐
tribution to the literature.
It is challenging to adequately compare the available evidence 
as several different methods were employed. For example, some 
authors report 1‐ or 2‐year survival rates, which is less informative 
than 5‐year survival, as patients may still be undergoing treatment 
and are not considered in remission (Parkin, Bray, Ferlay, & Pisani, 
2001). Other authors report length of survival, rather than mor‐
tality rates, which yields a different and non‐comparable outcome 
measure. Second, the way in which each study classifies remoteness 
status varied in important ways. Some studies simply compared 
non‐metropolitan to metropolitan and others represented remote‐
ness as a continuous “distance” variable. Considering that the effect 
of remoteness on survival or stage at diagnosis may not be entirely 
linear, these methods are problematic and may further confound our 
understanding of the true patterns of disparity.
4.2 | Recommendations
In order to determine the nature of geographic disparities in CRC 
survival and stage at diagnosis, population‐level studies need to be 
replicated and standardised. It is recommended that future research 
examine current data from each state of Australia separately using 
a consistent and robust method of defining and reporting survival 
and classifying geographical location. The use of 5‐year survival 
analyses and consistent categorisation of remoteness, preferably 
using a standard 3+ category system such as the ARIA would as‐
sist. Considering the implementation of the National Bowel Cancer 
Screening Program in 2006, it is recommended that CRC survival 
and stage of diagnosis be re‐addressed in a contemporary sample. 
Again, state‐by‐state comparisons and comparable categorisation 
of key variables are paramount in understanding if and where dis‐
parity exists, and where intervention is required. Research aimed at 
improving cancer outcomes and detection in regional areas should 
continue, however, more recent data are required to maintain an up‐
to‐date understanding of disparities.
5  | CONCLUSIONS
The purpose of this review was to provide an outline of geographic 
disparities in CRC survival and stage at diagnosis, to provide a 
foundation and reference point from which to examine any change 
that might occur following the introduction and roll‐out of the 
NBCSP. There is high‐quality evidence to suggest poorer five‐year 
survival outside of metropolitan areas in Australia, but this is in‐
fluenced by stage and type of cancer, specific geographic regions, 
and the time period from which the data were collected. This early 
evidence suggests geographic variations in survival of CRC exists 
which has an important impact on policy and services. However, 
the impact of population‐level screening needs to be further ex‐
plored, and the issue of non‐standardised reporting needs to be 
addressed. In general, while survival disparities are apparent, 
there does not appear to be a simple linear trend of disadvantage 
increasing with distance from metropolitan centres. This implies 
that geographic disparity is not simply related to remoteness, but 
likely linked to a range of individual, health system and disease‐
specific factors. Further research would be beneficial to ascertain 
to what extent differences in cancer screening and treatment op‐
tions affect survival for individuals diagnosed with CRC, so that 
healthcare services can be improved and interventions and policy 
changes can be guided by appropriate evidence. If data contin‐
ues to be reported in an unstandardised manner, this will limit our 
ability to detect any impact of population‐level CRC screening on 
stage at diagnosis and survival across differing geographic loca‐
tions. As we reach full implementation of population‐wide screen‐
ing in Australia it is important that we have an understanding of 
the current state of the survival and stage disparities in order to 
track progress moving forward. This can only be done if current 
data are routinely and reliably collected and reported.
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